Patents by Inventor Andre S. Bachmann

Andre S. Bachmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors
    Patent number: 9072778
    Abstract: The present invention relates to methods and compositions for treating diseases. More specifically, the present invention relates to the administration of multiple drugs as part of a treatment of disease. Specific embodiments of the invention relate to a treatment regimen for neuroblastomas and other N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors, comprising administering multiple therapeutic compounds like DFMO, SAM486A, a verinoid and a cytotoxic drug and placing the patient on a low polyamine diet and/or providing the patient with a polyamine limiting dietary supplement.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: July 7, 2015
    Assignee: UNIVERSITY OF HAWAII
    Inventor: Andre S. Bachmann
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RESPONSIVE TO PROTEASOME INHIBITION
    Publication number: 20140187526
    Abstract: The invention disclosed herein generally relates to methods and compositions for inhibiting proteasome activity comprising a syrbactin compound having the structure of Formula I or II:
    Type: Application
    Filed: December 2, 2013
    Publication date: July 3, 2014
    Applicant: Pono Corporation
    Inventors: Andre S. Bachmann, Robert Dudler, Michael Groll
  • Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition
    Patent number: 8597904
    Abstract: The invention disclosed herein generally relates to methods and compositions for inhibiting proteasome activity comprising a syrbactin compound have the structure of Formula (I) or (II).
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: December 3, 2013
    Assignee: Pono Corporation
    Inventors: Andre S. Bachmann, Robert Dudler, Michael Groll
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREAMENT OF CONDITIONS RESPONSIVE TO PROTEASOME INHIBITION
    Publication number: 20100267070
    Abstract: The invention disclosed herein generally relates to methods and compositions for inhibiting proteasome activity comprising a syrbactin compound have the structure of Formula (I) or (II).
    Type: Application
    Filed: November 14, 2008
    Publication date: October 21, 2010
    Applicant: University of Hawaii
    Inventors: Andre S. Bachmann, Robert Dudler, Michael Groll
  • TREATMENT REGIMEN FOR N-MYC, C-MYC, AND L-MYC AMPLIFIED AND OVEREXPRESSED TUMORS
    Publication number: 20090203784
    Abstract: The present invention relates to methods and compositions for treating diseases. More specifically, the present invention relates to the administration of multiple drugs as part of a treatment of disease. Specific embodiments of the invention relate to a treatment regimen for neuroblastomas and other N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors, comprising administering multiple therapeutic compounds like DFMO, SAM486A, a verinoid and a cytotoxic drug and placing the patient on a low polyamine diet and/or providing the patient with a polyamine limiting dietary supplement.
    Type: Application
    Filed: December 20, 2006
    Publication date: August 13, 2009
    Inventor: Andre S. Bachmann